{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T07:15:00Z","timestamp":1788074100927,"version":"build-2784847793"},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["RRCT"],"published-print":{"date-parts":[[2026,8,6]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Metabolic disorders, including obesity, type 2 diabetes (T2D), metabolic\nsyndrome, Non-Alcoholic Fatty Liver Disease (NAFLD), and Metabolic Dysfunction-Associated\nSteatotic Liver Disease (MASLD), represent major global health challenges. Increasing evidence\nsuggests that gut microbiota dysbiosis contributes to the development and progression of these disorders\nthrough mechanisms involving inflammation, insulin resistance, altered energy metabolism,\nand impaired intestinal barrier function. This review aimed to evaluate recent clinical evidence regarding\nthe effects of gut microbiota-targeted interventions on microbial composition and metabolic\noutcomes in individuals with metabolic disorders.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A narrative review of clinical studies published between 2021 and 2026 was conducted\nusing the PubMed electronic database. Studies investigating dietary interventions, probiotics, prebiotics,\nsynbiotics, Fecal Microbiota Transplantation (FMT), pharmacological therapies, bariatric surgery,\nand herbal formulations were included. Data regarding microbiota alterations and metabolic\noutcomes were extracted and qualitatively synthesized.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>A total of 36 clinical studies were included. Across the reviewed literature, microbiotatargeted\ninterventions consistently promoted beneficial alterations in gut microbial composition, including\nincreased abundance of Bifidobacterium, Akkermansia, Roseburia, Eubacterium, and other\nshort-chain fatty acid (SCFA)-producing bacteria. These microbial changes were associated with\nimprovements in insulin sensitivity, glycemic control, body weight, liver fat accumulation, lipid metabolism,\nand cardiometabolic risk markers. Dietary interventions and probiotic-based therapies\ndemonstrated the most consistent benefits, whereas FMT studies produced variable clinical outcomes\ndespite substantial microbiome remodeling.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion:<\/jats:title>\n                    <jats:p>The findings indicate that restoration of microbial homeostasis may represent a key\nmechanism underlying improvements in metabolic health. Increased abundance of beneficial microbial\ntaxa and enhanced SCFA production were consistently linked to favorable metabolic outcomes,\nsupporting the concept that the gut microbiome plays an active role in metabolic regulation. However,\nvariability among studies suggests that intervention efficacy may depend on baseline microbial\ncomposition, host characteristics, and treatment duration.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Current evidence supports the therapeutic potential of gut microbiota modulation in\nobesity, T2D, NAFLD, MASLD, and related metabolic disorders. Further large-scale, long-term\nclinical studies are required to establish causal relationships, identify predictive microbial biomarkers,\nand facilitate the development of personalized microbiome-based therapies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0115748871477574260803112949","type":"journal-article","created":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T06:46:08Z","timestamp":1788072368000},"update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comprehensive Overview of Gut Microbiota Alterations in Obesity and Related Chronic Diseases: A Narrative Review"],"prefix":"10.2174","volume":"21","author":[{"given":"Usha Rani","family":"Kandula","sequence":"first","affiliation":[{"name":"Department of Community Health Nursing, Cihan University-Erbil, Erbil, Kurdistan Region, Iraq"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huda Sdiq","family":"Bilal","sequence":"additional","affiliation":[{"name":"Department of Medical Laboratory Analysis, Cihan University-Erbil, Kurdistan Region, Iraq"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","container-title":["Reviews on Recent Clinical Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0115748871477574260803112949","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/257131\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0115748871477574260803112949","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T06:46:18Z","timestamp":1788072378000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/257131\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,6]]},"references-count":0,"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0115748871477574260803112949","relation":{},"ISSN":["1574-8871"],"issn-type":[{"value":"1574-8871","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8,6]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Double blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2026-03-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-06","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-16","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-06","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}